Our study has shown that SLC25A37 and SLC25A38 were over-expressed in RARS patients, and has identified one sequence change in the ALAD gene that could contribute to a better understanding of the pathogenesis of sideroblastic MDS. The gene discussed is SLC25A37; the disease is myelodysplastic syndrome.